查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1935699

合成生物学自动化平台市场：按组件、技术、应用和最终用户划分，全球预测（2026-2032年）

Synthetic Biology Automation Platform Market by Component, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，合成生物学自动化平台市场价值将达到 61.7 亿美元，到 2026 年将成长至 64.3 亿美元，到 2032 年将达到 88.7 亿美元，复合年增长率为 5.32%。

关键市场统计数据
基准年 2025 61.7亿美元
预计年份：2026年 64.3亿美元
预测年份 2032 88.7亿美元
复合年增长率 (%) 5.32%

这是一本策略性入门指南，说明了整合自动化平台如何重塑合成生物学实验的实验室通量、可重复性和决策。

合成生物学自动化平台处于实验室实践、计算分析和工业规模生物製造的关键交汇点。本文概述了该技术的范围、整合的复杂性以及推动其在研究和商业环境中应用的实际需求。文章全面阐述了仪器、软体和实验室工作流程的进步如何说明，从而实现新型的可重复性、高通量和数据驱动型生物学。

模组化系统、嵌入式人工智慧和跨学科融合是改变合成生物学平台的关键技术和营运转折点。

合成生物学自动化领域正经历一系列变革性转变，其影响远超过仪器设备的渐进式改进。其中最显着的转变包括：将先进的计算层整合到实验室硬体中、实现模组化和互操作系统的标准化，以及基于数据驱动的实验设计重新定义工作流程。这些因素共同作用，正在重塑价值链：物理自动化逐渐成为一种通用技术，而软体和分析技术则成为差异化的关键。

对近期美国关税政策变化将如何影响合成生物学自动化生态系统的供应链、采购决策和营运策略进行定性评估

美国新关税和贸易政策调整的推出可能会对合成生物学自动化生态系统产生累积影响，具体体现在供应链重组、成本分配和合规负担等。关税往往会增加国际采购硬体零件的到岸成本，促使采购团队重新评估供应商多元化和前置作业时间缓衝。对于需要特殊製造的设备和耗材，关税可能会奖励企业将生产外包或进行垂直整合，以寻求对关键上游投入的控制。

详细的細項分析解释了组件、技术、应用和最终用户方面的差异如何驱动差异化产品策略和采用趋势。

要充分了解合成生物学自动化领域的机会和风险，对市场区隔的正确理解至关重要。根据其组成要素，该市场可分为硬体、服务和软体三大类：硬体提供实现物理实验所需的设备和耗材；服务提供系统整合、培训和实验室营运管理；软体则提供将湿实验流程与数位化洞察相结合的编配、资料管理和分析功能。

区域趋势和政策主导解释了美洲、欧洲/中东/非洲和亚太地区不同的采用模式和采购行为。

区域趋势将对合成生物学自动化平台的普及速度和模式产生重大影响。在美洲，密集的研究和私营部门的投资共同推动了整合自动化解决方案的快速普及，製药和工业生物技术公司对规模化和合规性的重视尤为突出。北美实验室倾向于采用模组化系统，并强调软体驱动的编配和能够简化检验和部署的服务伙伴关係。

企业原型和策略行为揭示了合成生物学自动化领域製造商、软体供应商、整合商和服务供应商之间的竞争、合作和价值创造。

要了解合成生物学自动化生态系统中的企业行为，需要专注于其策略定位、产品系列和伙伴关係方式。主要参与者大致可分为几类：仪器製造商，强调可靠性和吞吐量；软体和分析提供商，专注于资料互通性和实验自动化；整合商和系统供应商，提供承包实验室自动化和工作流程编配；以及以服务为导向的机构，提供合约研究、实验室管理和客製化自动化实施方案。

产业领导者应采取切实可行的策略行动和营运重点，以降低自动化采用的风险并加快实现价值的时间。

产业领导者可以采取实际行动，加速合成生物学自动化平台的普及应用，降低风险，并创造价值。首先，应优先考虑硬体和软体元件之间的模组化互通性，以保持柔软性并避免供应商锁定。这种方法可以缩短整合前置作业时间，并支援迭代式工作流程改进。其次，应投资于人才培养，将技术培训和流程设计专业知识结合，使实验室团队能够在保持科学严谨性的同时，最大限度地提高自动化带来的生产力优势。

一项严谨的混合方法调查方法，结合了从业人员访谈、实验室检验、技术基准测试以及供应链和政策分析，得出了基于证据的结论。

本分析的调查方法结合了定性和定量调查、与关键相关人员的直接对话以及严谨的二手资料研究。主要资料来源包括对实验室经理、采购人员、自动化工程师和技术主管的深入访谈，以获取有关实施挑战、整合模式和供应商关係的第一手资讯。现场考察和实验室参观则用于观察工作流程配置，检验有关吞吐量、人体工学设计和系统互通性的说法。

一份概述组织在实施合成生物学自动化平台时应关注的策略要务和实际优先事项的摘要

总之，合成生物学自动化平台正在改变科学研究实验室和工业界设计、执行和扩展实验的方式。计算智慧、精准编辑工具、高通量仪器和灵活的流体处理技术的融合，正在实现生产力和可重复性的新高度。儘管政策变革和贸易措施带来了复杂性，但目前的趋势是倾向于模组化、以数据为中心且以稳健的服务模式为基础的系统。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 合成生物学自动化平台市场（依组件划分）

  • 硬体
  • 服务
  • 软体

9. 合成生物学自动化平台市场（依技术划分）

  • 人工智慧和机器学习
    • 资料探勘
    • 影像分析
    • 预测建模
  • 基于 CRISPR 的平台
    • 基础编辑系统
    • 基因编辑工具
  • 高通量定序
    • 次世代定序
    • 第三代定序
  • 微流体技术
    • 连续流微流体技术
    • 数位微流体技术
    • 液滴微流体技术
  • 机器人自动化
    • 桌上型机器人
    • 高通量自动化系统
    • 移动机器人

10. 合成生物学自动化平台市场（依应用领域划分）

  • 农业生物技术
  • 诊断
  • 工业生物加工
  • 治疗药物生产

第十一章 合成生物学自动化平台市场（依最终用户划分）

  • 学术研究机构
  • 合约研究机构
  • 政府研究机构
  • 工业生物技术公司
  • 製药和生物技术公司

12. 各地区合成生物学自动化平台市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

13. 合成生物学自动化平台市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国合成生物学自动化平台市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国合成生物学自动化平台市场

16. 中国合成生物学自动化平台市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Asimov, Inc.
  • Autodesk, Inc.
  • Codex DNA, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Integrated DNA Technologies, Inc.
  • LabGenius Ltd.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN NV
  • Synthace Ltd.
  • Synthego Corporation
Product Code: MRR-9A6A6F2974BA

The Synthetic Biology Automation Platform Market was valued at USD 6.17 billion in 2025 and is projected to grow to USD 6.43 billion in 2026, with a CAGR of 5.32%, reaching USD 8.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.17 billion
Estimated Year [2026] USD 6.43 billion
Forecast Year [2032] USD 8.87 billion
CAGR (%) 5.32%

A strategic primer detailing how integrated automation platforms are reshaping laboratory throughput, reproducibility, and decision-making across synthetic biology operations

Synthetic biology automation platforms are at a pivotal intersection of laboratory practice, computational analytics, and industrial-scale biomanufacturing. This introduction frames the breadth of technologies, the complexity of integration, and the practical imperatives driving adoption across research and commercial environments. It synthesizes how advances in instrumentation, software, and laboratory workflows are converging to enable reproducibility, throughput, and a new mode of data-driven biology.

As laboratories confront the dual pressures of accelerating discovery and controlling operational complexity, automation platforms are emerging as the connective tissue that harmonizes wet-lab processes with digital infrastructure. The introduction outlines the principal value propositions-reduced manual variability, accelerated experiment cycles, and enhanced traceability-while setting expectations for the subsequent sections, which examine technological inflections, policy-related headwinds, segmentation nuances, regional dynamics, corporate behavior, and practical recommendations for strategic leaders.

Key technological and operational inflection points showing how modular systems, embedded AI, and cross-disciplinary integrations are transforming synthetic biology platforms

The synthetic biology automation landscape is evolving through a set of transformative shifts that extend well beyond incremental improvements in instrumentation. The most notable transitions are the embedding of advanced computational layers into laboratory hardware, the normalization of modular and interoperable systems, and the redefinition of workflows around data-centric experiment design. Together these forces are altering the value chain: software and analytics increasingly determine differentiation even as physical automation becomes commoditized.

Moreover, cross-disciplinary convergence is facilitating novel use cases. Artificial intelligence and machine learning are moving from pilot projects to embedded orchestration, enabling closed-loop experimentation that shortens hypothesis-to-validation cycles. Parallel advances in microfluidics and high-throughput sequencing are driving a redistribution of experimental scale, allowing smaller labs to access capabilities once limited to centralized facilities. Consequently, collaboration models are shifting: partnerships between instrument OEMs, software developers, and end users are becoming the primary route to deliver integrated solutions rather than single-vendor propositions.

Qualitative assessment of how recent United States tariff shifts may reshape supply chains, procurement decisions, and operational strategies across synthetic biology automation ecosystems

The introduction of new tariff measures and trade policy adjustments in the United States can exert a meaningful cumulative effect on synthetic biology automation ecosystems, manifesting through supply chain reconfiguration, cost allocation, and compliance burden. Tariffs tend to increase landed costs for hardware components sourced internationally, prompting procurement teams to reassess supplier diversification and lead-time buffers. For instruments and consumables that require specialized manufacturing, tariffs can create incentives for nearshoring production or for vertical integration by companies seeking to control critical upstream inputs.

Operationally, increased import duties and trade friction expand the administrative overhead associated with international procurement. Companies respond by refining product classifications, optimizing bill-of-materials sourcing, and negotiating longer-term supply agreements to stabilize pricing. From a technology perspective, software and cloud-delivered capabilities are less directly affected by customs duties, but they can be impacted by ancillary effects such as reduced hardware deployments or changes in capital expenditure cycles. In addition, tariffs influence partnership strategies: vendors and end users may prioritize local alliances, contract research organizations, or domestic manufacturing capacity to mitigate exposure. Ultimately, the cumulative effects are most visible in procurement patterns, capital allocation priorities, and regional supply chain design rather than in immediate shifts to scientific practice.

An in-depth segmentation synthesis explaining how component, technology, application, and end-user distinctions drive differentiated product strategies and adoption dynamics

A precise understanding of segmentation is essential to navigate opportunity and risk within the synthetic biology automation domain. Based on component, the market differentiates among hardware, services, and software, with hardware encompassing instruments and consumables that enable physical experimentation, services covering system integration, training, and managed laboratory operations, and software providing orchestration, data management, and analytics that tie wet-lab processes to digital insights.

Based on technology, the landscape spans artificial intelligence and machine learning, CRISPR-based platforms, high-throughput sequencing, microfluidics, and robotic automation. Within artificial intelligence and machine learning, capabilities such as data mining, image analysis, and predictive modeling are extending the reach of automated experimentation. CRISPR-based platforms further segment into base editing systems and gene editing tools that vary by precision and application scope. High-throughput sequencing differentiates between next-generation sequencing and third-generation sequencing approaches that offer distinct trade-offs in read length and throughput. Microfluidics is expressed through continuous flow microfluidics, digital microfluidics, and droplet microfluidics, each enabling different scales and modalities of fluid handling. Robotic automation ranges from bench-top robots to high-throughput automation systems and mobile robotics that support flexible laboratory layouts.

Based on application, commercial and research priorities divide across agricultural biotechnology, diagnostics, industrial bioprocessing, and therapeutics production, with each application shaping requirements for throughput, regulatory compliance, and integration. Based on end user, adoption spans academic research institutions, contract research organizations, government research laboratories, industrial biotechnology firms, and pharmaceutical and biotechnology companies, reflecting diverse procurement cycles, validation needs, and tolerance for experimental risk. Together, these segmentation perspectives provide a multidimensional framework for assessing technology fit, go-to-market models, and investment priorities.

Regional dynamics and policy-driven variations that explain divergent adoption patterns and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics materially influence the pace and pattern of adoption for synthetic biology automation platforms. In the Americas, research intensity and private-sector investment combine to foster rapid uptake of integrated automation solutions, with strong demand from pharmaceutical companies and industrial biotechnology firms that prioritize scale and regulatory compliance. North American laboratories often favor modular systems with emphasis on software-driven orchestration and service partnerships that streamline validation and deployment.

In Europe, Middle East & Africa, heterogeneous regulatory frameworks and public-sector research initiatives shape adoption trajectories. Several European countries are advancing national strategies to support bioeconomy innovation, which encourages collaboration between academic institutions and industrial partners. Procurement practices in this region tend to emphasize interoperability, open standards, and long-term service agreements. In the Asia-Pacific region, a mix of aggressive public investment, manufacturing capacity, and rapidly expanding biotech sectors is accelerating both hardware production and in-country deployment. Governments are investing in local capability building, which combined with strong industrial demand, is encouraging localization of supply chains and the rise of regional integrators. Across regions, differences in funding models, regulatory requirements, and industrial priorities dictate distinct go-to-market tactics for vendors and service providers.

Corporate archetypes and strategic behaviors that reveal how manufacturers, software vendors, integrators, and service providers compete, collaborate, and create value in the synthetic biology automation space

Understanding corporate behavior within the synthetic biology automation ecosystem requires attention to strategic positioning, product portfolios, and partnership approaches. Key players generally fall into a few distinct archetypes: instrument manufacturers that emphasize reliability and throughput; software and analytics providers that focus on data interoperability and experiment automation; integrators and systems providers who deliver turnkey laboratory automation and workflow orchestration; and service-centric organizations that offer contract research, managed lab services, and customized automation deployments.

Strategically, companies are differentiating through vertical integration, open-platform strategies, and alliance formation. Some firms prioritize proprietary hardware-software synergy to lock in workflows and deliver predictable results, while others adopt an open-architecture approach to attract a broader ecosystem of application developers and equipment vendors. Collaboration with academic labs, CROs, and industrial partners remains a central route to validation and early adoption. In addition, corporate investment in after-sales support, training, and remote diagnostics is proving decisive for customer retention and expansion. Leadership teams that balance product innovation with practical deployment expertise tend to achieve deeper penetration into regulated and industrial applications.

Actionable strategic moves and operational priorities that industry leaders should implement to de-risk adoption and accelerate value capture from automation investments

Industry leaders can take concrete actions to accelerate adoption, reduce risk, and capture value from synthetic biology automation platforms. First, prioritize modular interoperability across hardware and software components to preserve flexibility and avoid vendor lock-in; this approach reduces integration lead time and supports iterative workflow refinement. Second, invest in workforce capability building that pairs technical training with process design expertise, enabling lab teams to extract the full productivity gains of automation while maintaining scientific rigor.

Third, develop procurement strategies that incorporate supplier diversity, total cost of ownership assessments, and scenario planning for trade policy shifts. Fourth, emphasize data governance frameworks that ensure provenance, auditability, and secure data flows between instruments and analytics stacks. Fifth, cultivate strategic alliances that combine domain expertise, systems integration, and commercial channels; these partnerships accelerate time to value for customers. Finally, pilot closed-loop experimentation projects that pair AI-driven decisioning with automated execution, using them as demonstrators to build internal capability and to validate ROI through operational metrics rather than theoretical projections.

A rigorous mixed-methods research approach combining practitioner interviews, laboratory validation, technical benchmarking, and supply chain and policy analysis to ensure evidence-based conclusions

The research methodology underpinning this analysis combined qualitative and quantitative inquiry, primary stakeholder engagement, and rigorous secondary research. Primary inputs included in-depth interviews with laboratory managers, procurement leads, automation engineers, and technology executives to capture firsthand perspectives on deployment challenges, integration patterns, and vendor relationships. Site visits and laboratory walkthroughs were used to observe workflow configurations and to validate claims about throughput, ergonomics, and system interoperability.

Secondary work encompassed a comprehensive review of scientific literature, patent filings, vendor technical documentation, and regulatory guidance to map technology capabilities and compliance considerations. Comparative product benchmarking and architectural assessments were conducted to evaluate interoperability, scalability, and support models. Finally, supply chain and policy analyses were performed to understand sourcing dependencies and the implications of trade measures. Together, these methods produced a balanced assessment that privileges practitioner experience and technical realities over promotional narratives.

A closing synthesis that articulates the strategic imperatives and practical priorities for organizations adopting synthetic biology automation platforms

In conclusion, synthetic biology automation platforms are reshaping how experiments are designed, executed, and scaled across research and industry. The convergence of computational intelligence, precision editing tools, high-throughput instrumentation, and flexible fluidic handling is enabling a new tier of productivity and reproducibility. While policy shifts and trade measures introduce complexity, the dominant trajectory favors systems that are modular, data-centric, and supported by robust service models.

Decision-makers should view automation as a strategic capability that extends beyond cost reduction to encompass accelerated innovation cycles, improved quality control, and new commercialization pathways. By aligning procurement, workforce development, and partnership strategies with technical realities, organizations can both mitigate risks associated with supply chain and trade uncertainty and unlock sustained operational advantage. The coming period will reward actors who integrate technical foresight with pragmatic execution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Synthetic Biology Automation Platform Market, by Component

  • 8.1. Hardware
  • 8.2. Services
  • 8.3. Software

9. Synthetic Biology Automation Platform Market, by Technology

  • 9.1. Artificial Intelligence And Machine Learning
    • 9.1.1. Data Mining
    • 9.1.2. Image Analysis
    • 9.1.3. Predictive Modeling
  • 9.2. Crispr-Based Platforms
    • 9.2.1. Base Editing Systems
    • 9.2.2. Gene Editing Tools
  • 9.3. High-Throughput Sequencing
    • 9.3.1. Next-Generation Sequencing
    • 9.3.2. Third-Generation Sequencing
  • 9.4. Microfluidics
    • 9.4.1. Continuous Flow Microfluidics
    • 9.4.2. Digital Microfluidics
    • 9.4.3. Droplet Microfluidics
  • 9.5. Robotic Automation
    • 9.5.1. Bench-Top Robots
    • 9.5.2. High-Throughput Automation Systems
    • 9.5.3. Mobile Robotics

10. Synthetic Biology Automation Platform Market, by Application

  • 10.1. Agricultural Biotechnology
  • 10.2. Diagnostics
  • 10.3. Industrial Bioprocessing
  • 10.4. Therapeutics Production

11. Synthetic Biology Automation Platform Market, by End User

  • 11.1. Academic Research Institutions
  • 11.2. Contract Research Organizations
  • 11.3. Government Research Laboratories
  • 11.4. Industrial Biotechnology Firms
  • 11.5. Pharmaceutical And Biotechnology Companies

12. Synthetic Biology Automation Platform Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Synthetic Biology Automation Platform Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Synthetic Biology Automation Platform Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Synthetic Biology Automation Platform Market

16. China Synthetic Biology Automation Platform Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Amyris, Inc.
  • 17.7. Asimov, Inc.
  • 17.8. Autodesk, Inc.
  • 17.9. Codex DNA, Inc.
  • 17.10. GenScript Biotech Corporation
  • 17.11. Ginkgo Bioworks, Inc.
  • 17.12. Integrated DNA Technologies, Inc.
  • 17.13. LabGenius Ltd.
  • 17.14. Merck KGaA
  • 17.15. Novozymes A/S
  • 17.16. QIAGEN N.V.
  • 17.17. Synthace Ltd.
  • 17.18. Synthego Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY IMAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PREDICTIVE MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BASE EDITING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GENE EDITING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTINUOUS FLOW MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIGITAL MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DROPLET MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY BENCH-TOP ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT AUTOMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MOBILE ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOPROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY THERAPEUTICS PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 225. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 235. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 237. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY CRISPR-BASED PLATFORMS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY MICROFLUIDICS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY ROBOTIC AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SYNTHETIC BIOLOGY AUTOMATION PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)